Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 49

1.

An economic analysis of the universal varicella vaccination program in the United States.

Zhou F, Ortega-Sanchez IR, Guris D, Shefer A, Lieu T, Seward JF.

J Infect Dis. 2008 Mar 1;197 Suppl 2:S156-64. doi: 10.1086/522135.

PMID:
18419391
2.

Cost-effectiveness of varicella vaccination programs: an update of the literature.

Rozenbaum MH, van Hoek AJ, Vegter S, Postma MJ.

Expert Rev Vaccines. 2008 Aug;7(6):753-82. doi: 10.1586/14760584.7.6.753. Review.

PMID:
18665775
3.

Clinical and economic considerations of vaccination against varicella.

Strassels SA, Sullivan SD.

Pharmacotherapy. 1997 Jan-Feb;17(1):133-9. Review.

PMID:
9017774
4.

Varicella vaccine effectiveness in the US vaccination program: a review.

Seward JF, Marin M, Vázquez M.

J Infect Dis. 2008 Mar 1;197 Suppl 2:S82-9. doi: 10.1086/522145. Review.

PMID:
18419415
5.

Varicella prevention in the United States: a review of successes and challenges.

Marin M, Meissner HC, Seward JF.

Pediatrics. 2008 Sep;122(3):e744-51. doi: 10.1542/peds.2008-0567. Review.

PMID:
18762511
6.

Cost containment analysis of childhood vaccination against varicella in Israel.

Ginsberg GM, Somekh E.

J Infect. 2004 Feb;48(2):119-33. Review.

PMID:
14720487
7.

American Academy of Pediatrics. Committee on Infectious Diseases. Varicella vaccine update.

[No authors listed]

Pediatrics. 2000 Jan;105(1 Pt 1):136-41. Review.

PMID:
10617719
9.

Economic evaluation of Varicella vaccination: results of a systematic review.

Unim B, Saulle R, Boccalini S, Taddei C, Ceccherini V, Boccia A, Bonanni P, La Torre G.

Hum Vaccin Immunother. 2013 Sep;9(9):1932-42. doi: 10.4161/hv.25228. Epub 2013 Jul 3. Review.

10.

Economic evaluations of varicella vaccination programmes: a review of the literature.

Thiry N, Beutels P, Van Damme P, Van Doorslaer E.

Pharmacoeconomics. 2003;21(1):13-38. Review.

PMID:
12484801
11.

[Varicella vaccine].

Bégué P.

Arch Pediatr. 1999 Sep;6(9):1005-9. Review. French.

PMID:
10519038
12.

The impact of varicella vaccination in the United States.

Hambleton S, Gershon AA.

Semin Pediatr Infect Dis. 2005 Jan;16(1):38-43. Review.

PMID:
15685148
13.

[Varicella disease and varicella vaccine. A literature review].

Frederiksen MS, Plesner AM, Stellfeld M.

Ugeskr Laeger. 2003 Jun 2;165(23):2387-91. Review. Danish.

PMID:
12840997
14.

Varicella: the vaccine and the public health debate.

Niederhauser VP.

Nurse Pract. 1999 Mar;24(3):74-6, 79, 83-4 passim. Review.

PMID:
10100242
15.

Varicella vaccination in Australia.

Macartney KK, Beutels P, McIntyre P, Burgess MA.

J Paediatr Child Health. 2005 Nov;41(11):544-52. Review.

PMID:
16398834
16.

Systematic review of models assessing the economic value of routine varicella and herpes zoster vaccination in high-income countries.

Damm O, Ultsch B, Horn J, Mikolajczyk RT, Greiner W, Wichmann O.

BMC Public Health. 2015 Jun 5;15:533. doi: 10.1186/s12889-015-1861-8. Review.

17.

The impact of the varicella vaccination program on herpes zoster epidemiology in the United States: a review.

Reynolds MA, Chaves SS, Harpaz R, Lopez AS, Seward JF.

J Infect Dis. 2008 Mar 1;197 Suppl 2:S224-7. doi: 10.1086/522162. Review.

PMID:
18419401
18.

Concerns regarding universal varicella immunization. Time will tell.

MacFarlane LL, Sanders ML, Carek PJ.

Arch Fam Med. 1997 Nov-Dec;6(6):537-41. Review.

PMID:
9371046
19.

Varicella-zoster virus vaccine.

White CJ.

Clin Infect Dis. 1997 May;24(5):753-61; quiz 762-3. Review. No abstract available.

PMID:
9142766
20.

Is Europe ready to embrace a policy of universal varicella vaccination?

Ramet J, Weil-Olivier C, Sedlak W; Confederation of the European Specialists of Paediatrics (CESP)/European Academy of Paediatrics (EAP) CESP/EAP..

Int J Clin Pract. 2005 Nov;59(11):1326-33. Review.

PMID:
16236088

Supplemental Content

Support Center